|
| |
IMS HealthWhether you are freshly out of an undergraduate or have an MBA under your belt, our firm offers an invigorating atmosphere and a challenging career option that can help you realize your full professional potential. With our driverse mox of top Pharma and Biotech clients,you will gain exposure to soving the most pressing issues facing pharmaceutical executives and as a result help shape a Heather future for us all
| Contact Details: |
| 80 Board Street,35th Floor |
| New York City |
| New York |
| 10004 |
| United States of America |
| Tel: | 1 646 274 1800 |
| Fax: | |
| Email: | infopandr@imshealth.com |
| WWW: | www.cambriabio.com/
|
|
Loading...
|
Recent Publications by IMS Health: |  |
Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes.
BACKGROUND: Basal cell carcinoma (BCC) is the most common form of skin... | 10th November, 2009
| Health Economics and Outcomes Research, IMS Health, Brussels, Belgium.
| J Drugs Dermatol. 2009 Nov;8(11):992-6.
|
Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis.
BACKGROUND: Patients with diabetes mellitus have been shown to be at high... | 22nd October, 2009
| Health Economics and Outcomes Research, IMS Health Incorporated,
| Pharmacoeconomics. 2009;27(6):479-90. doi:
DOI Direct Link |
The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study.
ABSTRACT: BACKGROUND: Recent data have shown that type 2 diabetes patients... | 7th October, 2009
| IMS
| BMC Endocr Disord. 2009 Oct 5;9:19.
DOI Direct Link |
Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study.
Treatment guidelines for dyslipidemic patients have focused on lipid... | 2nd October, 2009
| Health Economics and Outcomes Research, IMS Health, Falls Church,
| Am J Cardiovasc Drugs. 2009;9(5):299-308. doi:
DOI Direct Link |
An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.
AIMS: To determine the long-term health economic benefits associated with... | 28th August, 2009
| IMS Health,
| Diabet Med. 2009 Aug;26(8):803-14.
DOI Direct Link |
→View more IMS Health research publications. |
Press Releases on IMS Health:
|
 |
| Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER |
16th November, 2009 |
Par Pharmaceutical Companies, Inc. |
WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S. Food and Drug Administration
|
| Mylan Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories |
10th November, 2009 |
Mylan Inc. |
PITTSBURGH, Nov. 10 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S.
|
| Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009 |
9th November, 2009 |
Warner Chilcott plc |
ARDEE, Ireland, Nov. 9 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30,
|
| Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009 |
6th November, 2009 |
Par Pharmaceutical Companies |
-- Metoprolol: For the quarter ended October 3, 2009, net sales of
metoprolol succinate were $161.1 million, a decrease of 47% from the
second quarter 2009. The decrease was
|
| Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) |
6th November, 2009 |
|
PARIS, November 6 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the
discovery and development of novel antibiotics designed to overcome the
significant global problem of
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 664 times since April 2007, the link to the organisation's website has been followed 84 times Recent Search Terms used to find this page: Economic outcomes associated with microvascular complications of type 2 diabetes mellitus results from a US claims data analysis. | opportunities and threats facing IMS health | IMS Health Database | ims health health report global 2009 pdf | ims health 2009 trend report pdf | IMS health database | 646-274-1800 | IMS Health database Top pharmaceutical companies 2009 | IMS health switzerland career | IMS HEALTH 2009 | . Search for more companies in New York City Search for more companies in New York This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for IMS Health |
